openPR Logo
Press release

Pulmonary Arterial Hypertension (PAH) Market to Reach USD 13.5 Billion, Globally, by 2028 At a CAGR 5.4 %

Pulmonary Arterial Hypertension (PAH) Market, Pulmonary Arterial Hypertension (PAH) Market Size

Pulmonary Arterial Hypertension (PAH) Market, Pulmonary Arterial Hypertension (PAH) Market Size

The global Pulmonary Arterial Hypertension (PAH) market is estimated to attain a valuation of US$ 13.5 Bn by the end of 2028, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 5.4% during the forecast period, 2021-2028.

The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of the Pulmonary Arterial Hypertension (PAH) industry. The current and historical status of the market together with forecasted market size and trends are demonstrated in the assessment in simple manner. In addition, the report delivers data on the volume, share, revenue, production, and sales in the market.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐Ÿ๐จ๐ซ ๐š ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐จ๐Ÿ ๐ญ๐ก๐ข๐ฌ ๐ซ๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐š๐ญ (๐”๐ฌ๐ž ๐‚๐จ๐ซ๐ฉ๐จ๐ซ๐š๐ญ๐ž ๐Œ๐š๐ข๐ฅ ๐ˆ๐ ๐Ÿ๐จ๐ซ ๐๐ฎ๐ข๐œ๐ค ๐‘๐ž๐ฌ๐ฉ๐จ๐ง๐ฌ๐ž) - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1181

The report by TMR is the end-product of a study performed using different methodologies including the PESTEL, PORTER, and SWOT analysis. The study with the help of these models shed light on the key financial considerations that players in the Pulmonary Arterial Hypertension (PAH) market need to focus on identifying competition and formulate their marketing strategies for both consumer and industrial markets. The report leverages a wide spectrum of research methods including surveys, interviews, and social media listening to analyze consumer behaviors in its entirety.

๐๐ฎ๐ฅ๐ฆ๐จ๐ง๐š๐ซ๐ฒ ๐€๐ซ๐ญ๐ž๐ซ๐ข๐š๐ฅ ๐‡๐ฒ๐ฉ๐ž๐ซ๐ญ๐ž๐ง๐ฌ๐ข๐จ๐ง (๐๐€๐‡) ๐Œ๐š๐ซ๐ค๐ž๐ญ: ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐“๐ซ๐ž๐ง๐๐ฌ ๐š๐ง๐ ๐•๐š๐ฅ๐ฎ๐ž ๐‚๐ก๐š๐ข๐ง

The study on the Pulmonary Arterial Hypertension (PAH) market presents a granular assessment of the macroeconomic and microeconomic factors that have shaped the industry dynamics. An in-depth focus on industry value chain help companies find out effective and pertinent trends that define customer value creation in the market. The analysis presents a data-driven and industry-validated frameworks for understanding the role of government regulations and financial and monetary policies. The analysts offer a deep-dive into the how these factors will shape the value delivery network for companies and firms operating in the market.

๐๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐๐ซ๐ž๐ฆ๐ข๐ฎ๐ฆ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ | ๐ˆ๐ฆ๐ฆ๐ž๐๐ข๐š๐ญ๐ž ๐ƒ๐ž๐ฅ๐ข๐ฏ๐ž๐ซ๐ฒ ๐€๐ฏ๐š๐ข๐ฅ๐š๐›๐ฅ๐ž ๐š๐ญ - https://www.transparencymarketresearch.com/checkout.php?rep_id=1181<ype=S

๐๐ฎ๐ฅ๐ฆ๐จ๐ง๐š๐ซ๐ฒ ๐€๐ซ๐ญ๐ž๐ซ๐ข๐š๐ฅ ๐‡๐ฒ๐ฉ๐ž๐ซ๐ญ๐ž๐ง๐ฌ๐ข๐จ๐ง (๐๐€๐‡) ๐Œ๐š๐ซ๐ค๐ž๐ญ: ๐๐ซ๐š๐ง๐๐ข๐ง๐  ๐’๐ญ๐ซ๐š๐ญ๐ž๐ ๐ข๐ž๐ฌ ๐š๐ง๐ ๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐ข๐ฏ๐ž ๐’๐ญ๐ซ๐š๐ญ๐ž๐ ๐ข๐ž๐ฌ

๐’๐จ๐ฆ๐ž ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ค๐ž๐ฒ ๐ช๐ฎ๐ž๐ฌ๐ญ๐ข๐จ๐ง๐ฌ ๐ฌ๐œ๐ซ๐ฎ๐ญ๐ข๐ง๐ข๐ณ๐ž๐ ๐ข๐ง ๐ญ๐ก๐ž ๐ฌ๐ญ๐ฎ๐๐ฒ ๐š๐ซ๐ž:

What are some of the recent brand building activities of key players undertaken to create customer value in the Pulmonary Arterial Hypertension (PAH) market?
Which companies are expanding litany of products with the aim to diversify product portfolio?
Which companies have drifted away from their core competencies and how have those impacted the strategic landscape of the Pulmonary Arterial Hypertension (PAH) market?
Which companies have expanded their horizons by engaging in long-term societal considerations?
Which firms have bucked the pandemic trend and what frameworks they adopted to stay resilient?
What are the marketing programs for some of the recent product launches?

๐“๐ก๐ž ๐ฅ๐ข๐ฌ๐ญ ๐จ๐Ÿ ๐ค๐ž๐ฒ ๐ฉ๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ ๐จ๐ฉ๐ž๐ซ๐š๐ญ๐ข๐ง๐  ๐ข๐ง ๐ญ๐ก๐ž ๐๐ฎ๐ฅ๐ฆ๐จ๐ง๐š๐ซ๐ฒ ๐€๐ซ๐ญ๐ž๐ซ๐ข๐š๐ฅ ๐‡๐ฒ๐ฉ๐ž๐ซ๐ญ๐ž๐ง๐ฌ๐ข๐จ๐ง (๐๐€๐‡) ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ง๐œ๐ฅ๐ฎ๐๐ž๐ฌ ๐Ÿ๐จ๐ฅ๐ฅ๐จ๐ฐ๐ข๐ง๐  ๐ง๐š๐ฆ๐ž๐ฌ:

Actelion Pharmaceuticals, Ltd., Gilead Sciences, Inc., GlaxoSmithKline plc, Pfizer, Inc., and United Therapeutics Corporation

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐Ÿ๐จ๐ซ ๐œ๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง ๐จ๐Ÿ ๐ญ๐ก๐ข๐ฌ ๐ซ๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐š๐ญ - https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1181

๐๐ฎ๐ฅ๐ฆ๐จ๐ง๐š๐ซ๐ฒ ๐€๐ซ๐ญ๐ž๐ซ๐ข๐š๐ฅ ๐‡๐ฒ๐ฉ๐ž๐ซ๐ญ๐ž๐ง๐ฌ๐ข๐จ๐ง (๐๐€๐‡) ๐Œ๐š๐ซ๐ค๐ž๐ญ: ๐€๐ฌ๐ฌ๐ž๐ฌ๐ฌ๐ฆ๐ž๐ง๐ญ ๐จ๐Ÿ ๐€๐ฏ๐ž๐ง๐ฎ๐ž๐ฌ ๐š๐ง๐ ๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž ๐๐จ๐ญ๐ž๐ง๐ญ๐ข๐š๐ฅ ๐ข๐ง ๐Š๐ž๐ฒ ๐†๐ž๐จ๐ ๐ซ๐š๐ฉ๐ก๐ข๐ž๐ฌ

๐’๐จ๐ฆ๐ž ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ค๐ž๐ฒ ๐š๐ฌ๐ฉ๐ž๐œ๐ญ๐ฌ ๐ญ๐ก๐š๐ญ ๐ญ๐ก๐ž ๐ฌ๐ญ๐ฎ๐๐ฒ ๐š๐ง๐š๐ฅ๐ฒ๐ณ๐ž๐ฌ ๐š๐ง๐ ๐ฌ๐ก๐ž๐๐ฌ ๐ฅ๐ข๐ ๐ก๐ญ ๐š๐ซ๐ž:

Which regions are witnessing rise in investments in the supply chain networks?
Which countries seems to have benefitted from recent import and export policies?
Which regions have witnessed decline in consumer demand due to economic and political upheavals?
Which are some the key geographies that are likely to emerge as lucrative markets?
Which regions are expected to lose shares due to pricing pressures?
Which regions leading players are expected to expand their footprints in the near future?
What are some the sustainability trends impacting the logistics and supply chain dynamics in the Pulmonary Arterial Hypertension (PAH) market?
What are some of the demographic and economic environments that create new demand in developing economies?
How are changing government regulations shaping business strategies and practices?

๐Œ๐จ๐ซ๐ž ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐›๐ฒ ๐“๐ซ๐š๐ง๐ฌ๐ฉ๐š๐ซ๐ž๐ง๐œ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก -

๐‹๐ฎ๐ง๐  ๐‚๐š๐ง๐œ๐ž๐ซ ๐’๐ฎ๐ซ๐ ๐ž๐ซ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ

https://www.globenewswire.com/en/news-release/2023/02/20/2611485/0/en/Lung-Cancer-Surgery-Market-to-Reach-US-20-2-Bn-by-End-of-2031-TMR-Study.html

๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐ˆ๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง ๐’๐ฒ๐ฌ๐ญ๐ž๐ฆ ๐Œ๐š๐ซ๐ค๐ž๐ญ

https://www.globenewswire.com/en/news-release/2023/02/17/2610852/0/en/Healthcare-Information-System-Market-Value-to-Reach-US-457-7-Bn-by-2033-TMR-Study.html

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ

Nikhil Sawlani

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ ๐“๐ซ๐š๐ง๐ฌ๐ฉ๐š๐ซ๐ž๐ง๐œ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pulmonary Arterial Hypertension (PAH) Market to Reach USD 13.5 Billion, Globally, by 2028 At a CAGR 5.4 % here

News-ID: 3018514 • Views: โ€ฆ

More Releases from Transparency Market Research

Global Opioid Induced Constipation Treatment Market Set to Reach USD 5.2 Billion by 2036, Driven by Rising Opioid Use and Targeted Therapies
Global Opioid Induced Constipation Treatment Market Set to Reach USD 5.2 Billion โ€ฆ
The global opioid induced constipation (OIC) treatment market is witnessing steady and sustained growth as healthcare systems worldwide place increasing emphasis on comprehensive pain management and supportive care. Valued at US$ 2.9 billion in 2025, the market is projected to reach US$ 5.2 billion by 2036, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2036. Growth is primarily fueled by the rising prevalence of chronicโ€ฆ
Pneumatic Flux Chipper Market Expanding at 7.4% CAGR Through 2036 - By Product Type / By Impact Frequency | China โ€ข India โ€ข Japan โ€ข U.S.
Pneumatic Flux Chipper Market Expanding at 7.4% CAGR Through 2036 - By Product T โ€ฆ
The global Pneumatic Flux Chipper Market is set to witness sustained and resilient growth over the next decade, underpinned by expanding heavy manufacturing activities, rising welding and fabrication demand, and continuous investments in industrial infrastructure across emerging and developed economies. According to the latest industry analysis, the market was valued at US$ 760.5 Mn in 2025 and is projected to reach US$ 1,680.8 Mn by 2036, expanding at a compoundโ€ฆ
AI in Automotive Market Outlook 2036: Global Industry to Surge from US$ 19.8 Billion in 2025 to US$ 244.4 Billion at 27% CAGR
AI in Automotive Market Outlook 2036: Global Industry to Surge from US$ 19.8 Bil โ€ฆ
The AI in automotive market is entering a phase of exponential expansion, supported by rapid digitization of vehicles, growing safety mandates, and consumer demand for intelligent mobility. The global market was valued at US$ 19.8 Bn in 2025 and is projected to reach US$ 244.4 Bn by 2036, registering a remarkable CAGR of 27% from 2026 to 2036. This growth trajectory reflects the transition of automobiles from mechanically driven products toโ€ฆ
Hypodermic Needles Market to Reach US$ 7.9 Billion by 2036 on Rising Injectable Drug Demand
Hypodermic Needles Market to Reach US$ 7.9 Billion by 2036 on Rising Injectable โ€ฆ
The global hypodermic needles market was valued at approximately US$ 4.2 billion in 2025 and is projected to reach around US$ 7.9 billion by 2036, expanding at a CAGR of nearly 5.8% from 2026 to 2036, driven by the rising prevalence of diabetes, cancer, and chronic diseases, growing demand for injectable drugs and biologics, and the expansion of global vaccination and immunization programs; increasing adoption of safety-engineered and disposable needles,โ€ฆ

All 5 Releases


More Releases for Pulmonary

Innovation In Pulmonary Drug Delivery Devices Industry Trends Gaining Momentum i โ€ฆ
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Pulmonary Drug Delivery Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for pulmonary drug delivery devices has experienced significant growth in the past few years. The market is projected to increase from $49.52 billion in 2024 to $52.8 billion in 2025,โ€ฆ
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary โ€ฆ
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offersโ€ฆ
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027. Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion. Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOCโ€ฆ
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend ofโ€ฆ
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market โ€“ Boon for Diseased Lungs Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treatedโ€ฆ
03-15-2017 | Health & Medicine
TMR
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic โ€ฆ
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segmentsโ€ฆ